490
Views
23
CrossRef citations to date
0
Altmetric
Reviews

Long noncoding RNAs in liver cancer: what we know in 2014

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jun Zhao, Steven G. Gray, Catherine M. Greene & Matthew W. Lawless. (2019) Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer. Expert Review of Gastroenterology & Hepatology 13:3, pages 247-256.
Read now

Articles from other publishers (22)

Shi-Peng Li, Hai-Xu Xu, Yao Yu, Jin-Dan He, Zhen Wang, Yan-Jie Xu, Chang-Ying Wang, Hai-Ming Zhang, Rong-Xin Zhang, Jian-Jun Zhang, Zhi Yao & Zhong-Yang Shen. (2016) LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget 7:27, pages 42431-42446.
Crossref
Cissé Yacouba & Damandi Voulaniya Kampété. (2022) The role of LncRNAs in the development of cataracts. IP International Journal of Ocular Oncology and Oculoplasty 8:2, pages 109-114.
Crossref
Leiqing Wang, Junzhi Sheng, Haojie Zhang, Baoyuan Xie, Linbiao Xiang, Dong Liu, Xinyuan Zhang, Peihao Zhang & Jinjin Liu. (2021) The Association between Long Noncoding RNA over Expression and Poor Prognosis of Liver Cancer: A Meta-Analysis. Journal of Healthcare Engineering 2021, pages 1-10.
Crossref
Kunwei Niu, Shibin Qu, Xuan Zhang, Jimin Dai, Jianlin Wang, Ye Nie, Hong Zhang, Kaishan Tao & Wenjie Song. (2021) LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Shimaa E. Soliman, Abdel Monem A. ElTorgoman, Mohamed F.A. Assar, Naglaa S. El Abd, Suzy F. Gohar & Raouth E. Girgis. (2020) Biochemical and molecular study of long non-coding RNAs (HOTTIP, ZEB-AS1 and MEG-3) in hepatocellular carcinoma. Meta Gene 26, pages 100808.
Crossref
Nashwa El‐Khazragy, Amal Ali Elshimy, Safaa Shawky Hassan, Mohamed Hafez Shaaban, Ahmed Hamed Bayoumi, Hekmat M. El Magdoub, Sherief Ghozy, Ahmed Gaballah, Marwa M. Aboelhussein, Hoda H. Abou Gabal, Azzah M. Bannunah & Azza EL‐Sayed Mansy. (2020) lnc‐HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct‐acting antivirals therapy. Molecular Carcinogenesis 59:12, pages 1382-1391.
Crossref
Mohammad Sarfi, Maryam Abbastabar & Ehsan Khalili. (2019) Long noncoding RNAs biomarker‐based cancer assessment. Journal of Cellular Physiology 234:10, pages 16971-16986.
Crossref
Chit Tam, Jack Ho Wong, Stephen Kwok Wing Tsui, Tao Zuo, Ting Fung Chan & Tzi Bun Ng. (2019) LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Applied Microbiology and Biotechnology 103:12, pages 4649-4677.
Crossref
Gang Li, Hao Shi, Xinyi Wang, Bei Wang, Qianqian Qu, Haiyang Geng & Hongjun Sun. (2019) Identification of diagnostic long non‑coding RNA biomarkers in patients with hepatocellular carcinoma. Molecular Medicine Reports.
Crossref
Li-li Wu, Wen-pin Cai, Xin Lei, Ke-qing Shi, Xiang-yang Lin & Liang Shi. (2018) NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis. Journal of Cell Communication and Signaling 13:1, pages 99-112.
Crossref
Ji Ma & Yong Ding. (2018) RETRACTED: Geniposide suppresses growth, migration and invasion of MKN45 cells by down-regulation of lncRNA HULC. Experimental and Molecular Pathology 105:3, pages 252-259.
Crossref
Tao Yang, Xiaojun He, An Chen, Kai Tan & Xilin Du. (2018) RETRACTED: LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. Gene 670, pages 114-122.
Crossref
Baoqi Shi, Xuejun Zhang, Lumeng Chao, Yu Zheng, Yongsheng Tan, Liang Wang & Wei Zhang. (2018) Comprehensive analysis of key genes, microRNAs and long non‐coding RNAs in hepatocellular carcinoma. FEBS Open Bio 8:9, pages 1424-1436.
Crossref
Yonghua Mou, Dongguo Wang, Renwei Xing, Hanqiu Nie, Yiping Mou, Yang Zhang & Xianfei Zhou. (2018) Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Cancer Biomarkers 23:1, pages 95-106.
Crossref
Huaixiang Zhou, Qiuran Xu, Chao Ni, Song Ye, Xiaowu Xu, Xiaoge Hu, Jiahong Jiang, Yeting Hong, Dongsheng Huang & Liu Yang. (2018) Prospects of Noncoding RNAs in Hepatocellular Carcinoma. BioMed Research International 2018, pages 1-9.
Crossref
Liming Wu, Lele Zhang & Shusen Zheng. (2017) Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma. Oncology Letters 14:2, pages 1233-1239.
Crossref
Quan Zhang, Kentaro Matsuura, David E. Kleiner, Fausto Zamboni, Harvey J. Alter & Patrizia Farci. (2016) Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology. Journal of Translational Medicine 14:1.
Crossref
Kunkai Su, Qi Wang, Luoyang Qi, Dasong Hua, Jingjing Tao, Connor J. Mangan, Yijia Lou & Lanjuan Li. (2016) MicroRNA-674-5p/5-LO axis involved in autoimmune reaction of Concanavalin A-induced acute mouse liver injury. Toxicology Letters 258, pages 101-107.
Crossref
Xiaoying Jiang, Ronghui Lei & Qilan Ning. (2016) Circulating long noncoding RNAs as novel biomarkers of human diseases. Biomarkers in Medicine 10:7, pages 757-769.
Crossref
Lu Zhang, Xiaoqiao Liu, Xuegong Zhang & Ronghua Chen. (2015) Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets. Molecular Genetics and Genomics 291:3, pages 1035-1051.
Crossref
Wei Peng, Jianzhong Wu & Jifeng Feng. (2016) Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomedicine & Pharmacotherapy 79, pages 188-193.
Crossref
Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas & Konstantinos Mavridis. (2015) Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?. Gastroenterology Research and Practice 2015, pages 1-18.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.